{"nct_id":"NCT05267106","title":"Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations","status":"TERMINATED","status_verified_date":"2025-10","start_date":"2022-05-20","start_date_type":"ACTUAL","primary_completion_date":"2024-12-17","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-17","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}